A-SPINE Asia Co., Ltd.
A-SPINE Asia Co., Ltd., a medical device company, engages in the research, development, manufacture, and marketing of spinal implants and instruments in Taiwan, China, the Philippines, Australia, New Zealand, Iran, Vietnam, Indonesia, Spain, Trinidad, and Sri Lanka. The company offers spinal fixation systems, such as cervical anterior fixation, and thoracic and lumbar fixation systems; interbody … Read more
A-SPINE Asia Co., Ltd. (6758) - Net Assets
Latest net assets as of June 2025: NT$268.25 Million TWD
Based on the latest financial reports, A-SPINE Asia Co., Ltd. (6758) has net assets worth NT$268.25 Million TWD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$536.71 Million) and total liabilities (NT$268.46 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$268.25 Million |
| % of Total Assets | 49.98% |
| Annual Growth Rate | -2.41% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1.31 |
A-SPINE Asia Co., Ltd. - Net Assets Trend (2020–2024)
This chart illustrates how A-SPINE Asia Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for A-SPINE Asia Co., Ltd. (2020–2024)
The table below shows the annual net assets of A-SPINE Asia Co., Ltd. from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$270.79 Million | -1.17% |
| 2023-12-31 | NT$274.00 Million | -1.11% |
| 2022-12-31 | NT$277.08 Million | -4.18% |
| 2021-12-31 | NT$289.18 Million | -3.13% |
| 2020-12-31 | NT$298.51 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to A-SPINE Asia Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 48.2% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$39.33 Million | 14.52% |
| Common Stock | NT$134.71 Million | 49.75% |
| Other Comprehensive Income | NT$61.28 Million | 22.63% |
| Other Components | NT$35.47 Million | 13.10% |
| Total Equity | NT$270.79 Million | 100.00% |
A-SPINE Asia Co., Ltd. Competitors by Market Cap
The table below lists competitors of A-SPINE Asia Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Global Electrical Technology Corp
VN:GLT
|
$11.34K |
|
Centrum Finansowe Banku BPS SA
WAR:CFS
|
$11.36K |
|
Globalink Investment Inc. Warrants
NASDAQ:GLLIW
|
$11.38K |
|
AGR GROUP -A-
BE:3AG1
|
$11.39K |
|
Ryder Capital Ltd
AU:RYD
|
$11.33K |
|
SUOMINEN EO 250
F:1S0
|
$11.32K |
|
MARW.VA.(REA.) LS-000001
F:Z8U0
|
$11.32K |
|
Archroma Pakistan Ltd
KAR:ARPL
|
$11.31K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in A-SPINE Asia Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 273,998,000 to 270,792,000, a change of -3,206,000 (-1.2%).
- Net income of 8,411,000 contributed positively to equity growth.
- Dividend payments of 13,471,000 reduced retained earnings.
- Other comprehensive income increased equity by 1,591,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$8.41 Million | +3.11% |
| Dividends Paid | NT$13.47 Million | -4.97% |
| Other Comprehensive Income | NT$1.59 Million | +0.59% |
| Other Changes | NT$263.00K | +0.1% |
| Total Change | NT$- | -1.17% |
Book Value vs Market Value Analysis
This analysis compares A-SPINE Asia Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.00x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.81x to 2.00x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | NT$22.05 | NT$40.00 | x |
| 2021-12-31 | NT$21.36 | NT$40.00 | x |
| 2022-12-31 | NT$20.50 | NT$40.00 | x |
| 2023-12-31 | NT$20.23 | NT$40.00 | x |
| 2024-12-31 | NT$20.05 | NT$40.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently A-SPINE Asia Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.11%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.08%
- • Asset Turnover: 0.80x
- • Equity Multiplier: 1.87x
- Recent ROE (3.11%) is below the historical average (5.13%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 10.18% | 8.21% | 0.68x | 1.82x | NT$537.90K |
| 2021 | 6.14% | 5.73% | 0.62x | 1.73x | NT$-11.18 Million |
| 2022 | 2.89% | 2.43% | 0.65x | 1.84x | NT$-19.70 Million |
| 2023 | 3.36% | 2.35% | 0.76x | 1.88x | NT$-18.19 Million |
| 2024 | 3.11% | 2.08% | 0.80x | 1.87x | NT$-18.67 Million |
Industry Comparison
This section compares A-SPINE Asia Co., Ltd.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,274,214,400
- Average return on equity (ROE) among peers: 6.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| A-SPINE Asia Co., Ltd. (6758) | NT$268.25 Million | 10.18% | 1.00x | $11.34K |
| Health & Life Co., Ltd. (1781) | $372.58 Million | -4.71% | 1.15x | $12.97 Million |
| Hi-Clearance (1788) | $3.00 Billion | 11.98% | 0.65x | $104.25 Million |
| Radiant Innovation (3373) | $865.89 Million | -3.30% | 0.08x | $18.65 Million |
| Wellell Inc (4106) | $1.31 Billion | 13.81% | 0.24x | $37.12 Million |
| Rossmax International Ltd (4121) | $1.33 Billion | 1.93% | 1.30x | $38.32 Million |
| United Orthopedic (4129) | $1.77 Billion | 7.55% | 0.46x | $300.33 Million |
| Dynamic Medical Technologies (4138) | $1.76 Billion | 11.67% | 0.71x | $39.41 Million |
| Ok Biotech Co Ltd (4155) | $1.30 Billion | 9.66% | 0.71x | $44.61 Million |
| Bioptik Technology (4161) | $717.83 Million | 6.76% | 1.11x | $30.42 Million |
| EPS Bio Technology Corp. (4183) | $309.15 Million | 10.25% | 0.77x | $4.27 Million |